Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use
US-10072003-B2 · Sep 11, 2018 · US
Merck Canada Inc holds 26 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 26 |
| Recent patents | 0 |
| First publication | Mar 24, 2015 |
| Latest publication | Sep 11, 2018 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-10072003-B2 · Sep 11, 2018 · US
US-9994587-B2 · Jun 12, 2018 · US
US-9834526-B2 · Dec 5, 2017 · US
US-9822107-B2 · Nov 21, 2017 · US
US-2017305902-A1 · Oct 26, 2017 · US
Representative or frequently cited publications from precomputed assignee stats.
US-10072003-B2 · Sep 11, 2018 · US
US-9994587-B2 · Jun 12, 2018 · US
US-9834526-B2 · Dec 5, 2017 · US
US-9822107-B2 · Nov 21, 2017 · US
US-2017305902-A1 · Oct 26, 2017 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 26 |
| Human Necessities | 22 |
Answers are generated from the same data shown on this page.